Showing results (81-90 of 133) with videos related to

Sort By:
Pageof 14
Surgery Today|March 31, 2004
Effectiveness of peripheral hepatogastrostomy versus hepatojejunostomy in the treatment of obstructive cholestasis: results of an experimental modelMarc H Dahlke, Heiko Aselmann, Dilek Ceylan, et al.
World Journal of Gastroenterology|June 5, 2023
Prolonged hyperthermic intraperitoneal chemotherapy duration with 90 minutes cisplatin might increase overall survival in gastric cancer patients with peritoneal metastasesHeinrich Steinhoff, Miklos Acs, Sebastian Blaj, et al.
Clinical Colorectal Cancer|August 23, 2018
Perioperative Systemic Chemotherapy, Cytoreductive Surgery, and Hyperthermic Intraperitoneal Chemotherapy in Patients With Colorectal Peritoneal Metastasis: Results of the Prospective Multicenter Phase 2 COMBATAC TrialGabriel Glockzin, Florian Zeman, Roland S Croner, et al.
Stem Cells (Dayton, Ohio)|November 18, 2006
No contribution of multipotent mesenchymal stromal cells to liver regeneration in a rat model of prolonged hepatic injuryFelix C Popp, Przemyslaw Slowik, Elke Eggenhofer, et al.
Onkologie|December 17, 2008
[Treatment of nonresectable liver metastases]Markus Moehler, Karsten Ridwelski, Meinolf Karthaus, et al.
Innovative Surgical Sciences|June 3, 2024
Current clinical practices of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)Miklos Acs, Maximilian Babucke, Maximilian Jusufi, et al.
Cancers|August 12, 2022
Total Neoadjuvant Therapy for Rectal Cancer in the CAO/ARO/AIO-12 Randomized Phase 2 Trial: Early Surrogate Endpoints RevisitedMarkus Diefenhardt, Anke Schlenska-Lange, Thomas Kuhnt, et al.
Cancer|April 22, 2011
A novel tumor-node-metastasis (TNM) staging system of diffuse malignant peritoneal mesothelioma using outcome analysis of a multi-institutional database*Tristan D Yan, Marcello Deraco, Dominique Elias, et al.
BMC Cancer|February 16, 2020
Neoadjuvant chemotherapy with gemcitabine plus cisplatin followed by radical liver resection versus immediate radical liver resection alone with or without adjuvant chemotherapy in incidentally detected gallbladder carcinoma after simple cholecystectomy or in front of radical resection of BTC (ICC/ECC) - a phase III study of the German registry of incidental gallbladder carcinoma platform (GR)- the AIO/ CALGP/ ACO- GAIN-trialThorsten O Goetze, Wolf O Bechstein, Ulli Simone Bankstahl, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 3, 2007
Targeting heat shock protein 90 in pancreatic cancer impairs insulin-like growth factor-I receptor signaling, disrupts an interleukin-6/signal-transducer and activator of transcription 3/hypoxia-inducible factor-1alpha autocrine loop, and reduces orthotopic tumor growthSven A Lang, Christian Moser, Andreas Gaumann, et al.
Pageof 14